Bionano Genomics, Inc. (BNGO)

USD 0.21

(-0.47%)

Gross Profit Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual gross profit in 2023 was 9.56 Million USD , up 60.91% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly gross profit in 2024 Q2 was 2.58 Million USD , down -8.46% from previous quarter.
  • Bionano Genomics, Inc. reported a annual gross profit of 5.94 Million USD in annual gross profit 2022, up 53.46% from previous year.
  • Bionano Genomics, Inc. reported a annual gross profit of 3.87 Million USD in annual gross profit 2021, up 39.71% from previous year.
  • Bionano Genomics, Inc. reported a quarterly gross profit of 2.82 Million USD for 2024 Q1, up 15.83% from previous quarter.
  • Bionano Genomics, Inc. reported a quarterly gross profit of 2.74 Million USD for 2023 Q3, up 19.11% from previous quarter.

Annual Gross Profit Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Gross Profit of Bionano Genomics, Inc. (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 9.56 Million USD 60.91%
2022 5.94 Million USD 53.46%
2021 3.87 Million USD 39.71%
2020 2.77 Million USD -17.51%
2019 3.36 Million USD 2.19%
2018 3.28 Million USD -5.33%
2017 3.47 Million USD 8.1%
2016 3.21 Million USD 0.0%

Peer Gross Profit Comparison of Bionano Genomics, Inc.

Name Gross Profit Gross Profit Difference
Prenetics Global Limited 8.82 Million USD -8.337%
Star Equity Holdings, Inc. 11.92 Million USD 19.789%
CareDx, Inc 178.32 Million USD 94.636%
Exact Sciences Corporation 1.84 Billion USD 99.482%
Exagen Inc. 29.45 Million USD 67.524%
Inotiv, Inc. 165.44 Million USD 94.218%
Guardant Health, Inc. 336.89 Million USD 97.161%
Biodesix, Inc. 36.07 Million USD 73.484%
BioNexus Gene Lab Corp. 1.32 Million USD -619.52%
Precipio, Inc. 6.01 Million USD -58.956%
iSpecimen Inc. 5.1 Million USD -87.278%
Natera, Inc. 492.74 Million USD 98.059%
Aspira Women's Health Inc. 5.26 Million USD -81.794%
Standard BioTools Inc. 50.45 Million USD 81.039%
23andMe Holding Co. 99.37 Million USD 90.374%
Castle Biosciences, Inc. 174.8 Million USD 94.528%
Personalis, Inc. 18.2 Million USD 47.463%
Aclaris Therapeutics, Inc. 13.16 Million USD 27.354%
Applied DNA Sciences, Inc. 5.53 Million USD -72.876%
OpGen, Inc. -90.69 Thousand USD 10647.556%
T2 Biosystems, Inc. -8.17 Million USD 217.087%
Myriad Genetics, Inc. 476.4 Million USD 97.992%
ICON Public Limited Company 1.81 Billion USD 99.473%
NeoGenomics, Inc. 244.6 Million USD 96.089%
Star Equity Holdings, Inc. 11.92 Million USD 19.789%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.563%
RadNet, Inc. 93 Million USD 89.714%
MDxHealth SA 43.92 Million USD 78.224%
Psychemedics Corporation 8.41 Million USD -13.705%
Illumina, Inc. 2.74 Billion USD 99.651%
Check-Cap Ltd. -212 Thousand USD 4612.264%
Twist Bioscience Corporation 133.34 Million USD 92.826%
DarioHealth Corp. 5.98 Million USD -59.86%
Fulgent Genetics, Inc. 104.45 Million USD 90.842%
Sera Prognostics, Inc. 96 Thousand USD -9864.583%
ENDRA Life Sciences Inc. -275.45 Thousand USD 3572.85%
OPKO Health, Inc. 318.12 Million USD 96.993%
Medpace Holdings, Inc. 524.5 Million USD 98.176%
Neogen Corporation 463.9 Million USD 97.938%
Intelligent Bio Solutions Inc. 1.42 Million USD -571.003%
Prenetics Global Limited 8.82 Million USD -8.337%
Mainz Biomed B.V. 509.65 Thousand USD -1776.941%
bioAffinity Technologies, Inc. 791.61 Thousand USD -1108.416%
Trinity Biotech plc 19.45 Million USD 50.817%
Neuronetics, Inc. 51.7 Million USD 81.499%
Sotera Health Company 577.15 Million USD 98.343%
bioAffinity Technologies, Inc. 791.61 Thousand USD -1108.416%